A virologist uses CRISPR-Cas13 to target viral RNA and finds that each guide RNA can degrade 8 viral RNA strands, but efficiency drops by 10% after each cycle due to immune response. After 5 cycles, how many total viral strands can one guide RNA degrade, assuming cumulative effectiveness?

As viral diseases remain a central focus in public health and scientific innovation, recent breakthroughs using CRISPR-Cas13 have drawn growing attention. Researchers are exploring how this powerful gene-editing tool can target and dismantle viral RNA to combat infections—particularly relevant amid rising awareness of viral threats and advancements in precision medicine.

Understanding the true degradation capacity of CRISPR-Cas13 across multiple cycles reveals both promise and biological limits. Early studies show each guide RNA effectively targets and destroys 8 viral RNA strands initially, but efficiency declines by 10% per cycle due to the body’s immune response. This gradual drop means performance isn’t constant—iteration and timing become key.

Understanding the Context

How Does the Efficiency Drop Impact Total Degradation?

A virologist uses CRISPR-Cas13 to target viral RNA and finds that each guide RNA can degrade 8 viral RNA strands initially, but efficiency diminishes by 10% after every cycle. After 5 cycles, total degradation isn’t a simple multiplication—it reflects cumulative effectiveness under changing conditions.

This stepwise decline illustrates a non-linear biological response: the first few cycles achieve near-full efficiency, while later cycles strain performance. Understanding this pattern helps frame realistic expectations in both research and potential future applications.

Calculating Total Viral RNA Degraded Over 5 Cycles

Key Insights

To determine total viral strands degraded across 5 cycles:
Cycle 1: 8 strands
Cycle 2: 8 × 0.9 = 7.2 strands
Cycle 3: 8 × 0.9² ≈ 6.48 strands
Cycle 4: 8 × 0.9³ ≈ 5.83 strands
Cycle 5: 8 ×